Skip to content

IAS: Lack of data on men with weak immune systems weakens study comparing safety of circumcision in HIV-positive and HIV-negative men

IAS: Maraviroc slightly less effective but more tolerable in treatment-naive patients

IAS: Low rates of HIV transmission in breastfeeding women on ART

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

IAS: Aciclovir treatment doesn't significantly reduce HIV or HSV-2 shedding in genital secretions